The vesicular monoamine transporter 2 (VMAT2) is expressed by normal and tumor cutaneous mast cells and langerhans cells of the skin but is absent from langerhans cell histiocytosis

Journal of Histochemistry and Cytochemistry

Volumn 52, Issue 6, 2004, Pages 779-788

  Anlauf, Martin ^a   Schafer, Martin K H ^a   Depboylu, Candan ^a,c   Hartschuh, Wolfgang ^d   Eiden, Lee E ^e   Kloppel, Guenter ^b   Weihe, Eberhard ^a,f  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f Inst of Anatomy and Cell Biology   (Germany)

Author keywords

Birbeck granules; CD1a; Dendritic cell; Histamine; Mast cell; Mastocytosis; Serotonin; Tryptase; Vesicular monoamine transporter

Indexed keywords

MONOAMINE; T6 ANTIGEN; TRYPTASE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 2; VESICULAR TRANSPORT PROTEIN;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; FEMALE; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; LANGERHANS CELL; MALE; MAST CELL; MASTOCYTOSIS; MONOAMINE RELEASE; MONOAMINERGIC SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECRETORY GRANULE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LANGERHANS CELLS; MALE; MAST CELLS; MASTOCYTOSIS, CUTANEOUS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEUROPEPTIDES; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

ANIMALIA;

EID: 2542583068     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4A6264.2004     Document Type: Article

References (58)

1. Allan RS, Smith CM, Belz GT, van Lint AL, Wakim LM, Heath WR, Carbone FR (2003) Epidermal viral immunity induced by CD8α+ dendritic cells but not by Langerhans cells. Science 301:1925-1928
2. Amenta F, Bronzetti E, Cantalamessa F, El-Assouad D, Felici L, Ricci A, Tayebati SK (2001) Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. J Neuroimmunol 117:133-142
3. Angerer LM, Stoler MH, Angerer RC (1987) In situ hybridization with RNA probes: an annoted recipe. In Valentino L, Eberwine I, Barchas D, eds. In Situ Hybridization: Application to Neurobiology. New York, Oxford University Press, 42-70
4. Anlauf M, Eissele R, Schafer MKH, Eiden LE, Arnold R, Pauser U, Kloppel G, et al. (2003a) Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors. J Histochem Cyotchem 51:1027-1040
5. Anlauf M, Schafer MKH, Eiden LE, Weihe E (2003b) Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic and catecholaminergic phenotypes. J Comp Neurol 459:90-111
6. Atkins FM, Clark RAF (1987) Mast cells and fibrosis. Arch Dermatol 123:191-193
7. Axelsson S, Elofsson R, Falck B, Sjöborg S (1978) In vitro uptake of L-dopa and catecholamines into the epidermal Langerhans-cell. Acta Dermatol Venerol Suppl (Stockh) 58:31-35
8. Bartosik J (1992) Cytomembrane-derived Birbeck granules transport horseradish peroxidase to the endosomal compartment in the human Langerhans cells. J Invest Dermatol 99:53-58
9. Birbeck MS, Brethnach AS, Everall JD (1961) An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 37:51-63
10. Crivellato E, Damiani D, Mallardi F (1990) Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti T-6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis. Acta Histochem 88:59-64
11. Eiden LE (2000) The vesicular neurotransmitter transporters: current perspectives and future prospects. FASEB J 14:2396-2400
12. Eiden LE, Schütz B, Anlauf M, Depboylu C, Schafer MKH, Weihe E (2002) The vesicular monoamine transporters (VMATs): role in the chemical coding of neuronal transmission and monoamine storage in amine-handling immune and inflammatory cells. In Nagatsu T, Nabeshima T, McCarty R, Goldstein DS, eds. Catecholamine Research: From Molecular Insights to Clinical Medicine. Advances in Behavioural Biology. New York, Kluwer Academic Publishers, 53:23-24
13. Eissele R, Anlauf M, Schafer MK, Eiden LE, Arnold R, Weihe E (1999) Expression of vesicular monoamine transporters in endocrine hyperplasia and endocrine tumors of the oxyntic stomach. Digestion 60:428-439
14. Erickson JD, Eiden LE (1993) Functional identification and molecular cloning of a human brain vesicle monoamine transporter. J Neurochem 61:2314-2317
15. Erickson JD, Eiden LE, Hoffman B (1992) Expression cloning of a reserpine sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA 89:10.993-10.997
16. Erickson JD, Schäfer K, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and neuroendocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166-5171
17. Erickson JD, Varoqui H (2000) Molecular analysis of vesicular amine transporter function and targeting to secretory organelles. FASEB J 14:2450-2458
18. Falck B, Andersson L, Mikulowska A, Ronquist G (1993) Alpha-Amino-n-butyric acid methyl ester induces concentrative uptake of L-dopa in hman Langerhans cells normally not operative for L-dopa transport. Acta Dermatol Venerol 73:197-199
19. Horny HP, Kaiserling E (1987) Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis a histological and immunohistological study. Br J Haematol 69:449-455
20. Horny HP, Kaiserling E, Campbell M, Parwaresch MR, Lennert K (1989) Liver findings in generalized mastocytosis. A clinico-pathologic study. Cancer 63:532-538.
21. Horny HP, Parwaresch MR, Lennert K (1985) Bone marrow findings in systemic mastocytosis. Hum Pathol 16:808-814
22. Horny HP, Ruck MT, Kaiserling E (1992) Spleen findings in generalized mastocytosis. A clinicopathologic study. Cancer 70:459-468
23. Horny HP, Sillaber C, Menke D, Kaiserling E, Wehrmann M, Stehberger B, Chott A, et al. (1998) Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 22:1132-1140
24. Horny HP, Valent P (2001) Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leukocyte Res 25:543-551
25. Ishii M, Terao Y, Kitajima JI, Hamada T (1984) Sequential production of Birbeck granules through adsorptive pinocytosis. J Invest Dermatol 82:28-29
26. Jakobsen AM, Andersson P, Saglik G, Andersson E, Kölby L, Erickson JD, Forssell-Aronsson E, et al. (2001) Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal neuroendocrine tumors. J Pathol 195:463-472
27. Katou F, Ohtani H, Saaristo A, Nagura H, Motegi K (2000) Immunological activation of dermal Langerhans cells in contact with lymphocytes in a model of human inflamed skin. Am J Pathol 156:519-527
28. Klareskog L, Tjernlund U, Forsum U, Peterson PA (1977) Epidermal Langerhans cells express Ia antigens. Nature 268:248-250
29. Krenacs L, Tiszalvicz L, Krenacs T, Boumsell L (1993) Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010. J Pathol 171:99-104
30. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C (1990) Evidence that cutaneous antigen presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 145:2833-2838
31. Lennert K, Parwaresch MR (1979) Mast cells and mast cell neoplasia: a review. Histopathology 3:349-365
32. Kunzmann S, Mantel PY, Wohlfahrt JG, Akdis M, Blaser K, Schmidt-Weber CB (2003) Histamine enhances TGF-beta1-mediated suppression of Th2 responses. FASEB J 17:1089-1095
33. Li WV, Kapadia SB, Sonmez-Alpan E, Swerdlow SH (1996) Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies. Mod Pathol 9:982-988
34. Liu Y, Peter D, Roghani A, Schuldiner S, Prive G, Eisenberg D, Brecha N, Edwards RH (1992) A cDNA that suppresses Mpp+ toxicity encodes a vesicular amine transporter. Cell 70:539-551
35. Longley J, Duffy TP, Kohn S (1995) The mast cell and mast cell disease. J Am Acad Dermatol 32:545-561
36. Maestroni GJ (2000) Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J Immunol 165:6743-6747
37. Maurer M, Opitz M, Henz BM, Paus R (1997) The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ. J Dermatol Sci 16:79-84
38. Mazzoni A, Leifer CA, Mullen GE, Kennedy MN, Klinman DM, Segal DM (2003) Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J Immunol 170:2269-2273
39. McDermott, Ziylan U, Spehner D, Bausinger H, Lipsker D, Mommaas M, Cazenave JP, et al. (2002) Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. Mol Biol Cell 13:317-335
40. Melman SA (1987) Mast cells and their mediators. Int J Dermatol 26:335-344
41. Moll H, Fuchs H, Blank C, Rollinghoff M (1993) Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 23:1595-1601
42. Mommaas AM, Wijsman MC, Mulder AA, van Praag MC, Vermeer BJ, Koning F (1992) HLA class II expression on human epidermal Langerhans cells in situ: upregulation during the elicitation of allergic contact dermatitis. Hum Immunol 34:99-106
43. Moseley RP, Brown JI, Auld J, Mumtaz H, Rainey AJ, Kirkham N, Gelsthorpe K, et al. (1997) An immunocytochemical study of MHC class I expression on human Langerhans cells and melanocytes. J Pathol 181:419-425
44. Rausch DM, Heyes MP, Murray EA, Lendvay J, Sharer LR, Ward JM, Rehm S, et al. (1994) Cytopathologic and neurochemical correlates of progression to motor/cognitive impairment in SIV-infected rhesus monkey. J Neuropathol Exp Neurol 53:165-175
45. Salamero J, Bausinger H, Mommaas AM, Lipsker D, Proamer F, Cazenave JP, Goud B, et al. (2001) CD1a molecules traffic through the early recycling endosomal pathway in human Langerhans cells. J Invest Dermatol 116:401-408
46. Schulinger S, Shirvan A, Linial M (1995) Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev 75:369-392
47. Schutz B, Schäfer MKH, Eiden LE, Weihe E (1998) Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut. Dev Brain Res 106:181-204
48. Seiffert K, Hosoi J, Torii H, Ozawa H, Ding W, Campton K, Wagner JA, et al. (2002) Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 168:6128-6135
49. Sjoborg S, Axelsson S, Falck B, Jacobsson S, Ringberg A (1978) A new method for the visualization of the epidermal Langerhans cell and its application on normal and allergic skin. Acta Dermatol Venereol Suppl (Stockh) 58:23-30
50. Tada J, Toi Y, Arata J (2000) Migrating mast cells into the epidermis of wet and inflammatory granuloma. Clin Exp Dermatol 25:258-259
51. Taylor RS, Baadsgaard O, Hammerberg C, Cooper KD (1991) Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. J Immunol 147:3794-3802
52. Travis ER, Wang YM, Michael DJ, Caron MG, Wightman RM (2000) Differential quantal release of histamine and 5-hydroxytryptamine from mast cells of vesicular monoamine transporter 2 knockout mice. Proc Natl Acad Sci USA 97:162-167
53. Uno H, Hanifin JM (1980) Langerhans cells in acute and chronic epidermal lesions of dermatitis, observed by L-dopa histofluorescence, glycol methacrylate thin secretion, and electron microscopy. J Invest Dermatol 75:52-60
54. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nunez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM (2001) Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 25:603-625
55. Watson F, Deavall DG, Macro JA, Kiernan R, Dimaline R (1999) Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123. Biochem J 337:193-199
56. Weihe E, Schäfer MKH, Erickson JD, Eiden LE (1994) Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to neuroendocrine cells and neurons in rat. J Mol Neurosci 5:149-164
57. Weihe E, Eiden LE (2000) Chemical neuroanatomy of the vesicular amine transporters. FASEB 14:2435-2449
58. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG (1994). Langerhans-cell histiocytosis (Histiocytosis X)-a clonal proliferative disease. N Engl J Med 331:154-160